# University of Melbourne

> University of Melbourne is a VC fund backing Health Care and Biotechnology. See 18 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Melbourne, Australia
- Total investments: 18
- Last investment: Oct 2025
- Lead investor: 28%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/5677
- X (Twitter): http://twitter.com/unimelb
- Website: http://unimelb.edu.au
- Facebook: http://www.facebook.com/melbuni

University of Melbourne is a VC fund in Melbourne focused on Health Care and Biotechnology. Established in 1853, the University of Melbourne is a public-spirited institution that makes distinctive contributions to society in research, learning and teaching and engagement. It’s consistently ranked among the leading universities in the world, with international rankings of world universities placing it as number 1 in Australia and number 33in the world (Times Higher Education World University Rankings 2014-2015).

## Contacts

5 contacts available for University of Melbourne. Shizune tracks 15 team members at University of Melbourne. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/the-university-of-melbourne?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 33% |
| Biotechnology | 6 | 33% |
| Medical | 4 | 22% |
| Software | 4 | 22% |
| Information Technology | 3 | 17% |

37 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 6 | 33% |
| Grant | 3 | 17% |
| Seed | 2 | 11% |
| Series A | 2 | 11% |
| Funding Round | 2 | 11% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Australia | 13 | 72% |
| United States | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Cathy Humphreys | Professor | 0 | https://shizune.co/investors/profile/cathy-humphreys |
| James Demetriou | Business Development Director | 0 | https://shizune.co/investors/profile/james-demetriou |
| Jane Gunn | Head of Department, Chair of Primary Care Research, Director of the Primary Care Research Unit | 0 | https://shizune.co/investors/profile/jane-gunn |
| Jennifer Henry | Senior Gifts in Wills Manager | 0 | https://shizune.co/investors/profile/jennifer-henry |
| Matthew Watson | Academic Tutor | 0 | https://shizune.co/investors/profile/matthew-watson-2015 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PredicTx Health | PredicTx Health provides AI platform that uses 3D body composition analysis to personalise chemo dosing based on body composition analysis | $1.6M | Pre-Seed | Oct 14, 2025 |  |
| CliniScribe AI | CliniScribe AI is an APA (Australian Physiotherapy Association) PitchFest 2023 finalist and backed by the Melbourne Accelerator Program (MAP25), the University of Melbourne’s startup accelerator. We develop clinician-focused AI tools designed to simplify paperwork, streamline healthcare workflows, and meaningfully enhance patient outcomes. | $12.4K | Grant | Mar 01, 2025 |  |
| The Leaf Protein Company | Our mission is to combine tradition, science and technology to produce highly nutritious ingredients that are both sustainable for the environment and for local grower communities. | $566.4K | Pre-Seed | Jun 12, 2024 |  |
| Psychae Therapeutics | Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses | $2.9M | Pre-Seed | Nov 13, 2023 |  |
| Kali Healthcare | Kali Healthcare is a multidisciplinary team of obstetricians and engineers dedicated to revolutionizing pregnancy monitoring. It's creating technology that will make pregnancy monitoring services more accessible and convenient for all women. | $500K | Pre-Seed | Mar 08, 2023 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 16, 2022 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 15, 2022 |  |
| Tiny Bright Things | Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent). | $1.5M | Seed | Nov 03, 2022 |  |
| AIBUILD | Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big dataand software solutions for clients in industries ranging from the real estate industry to education and research, including:JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical)MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart)HousePro – Innovative real-time VR+AI matching system in global real-estate industryCrowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council)Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne)A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT)We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers. | $18K | Seed | Nov 24, 2021 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $40M | Series B | Jun 03, 2021 |  |

10 of 18 investments shown.

## Co-investors
- [Forepont Capital Partners](https://shizune.co/investors/profile/forepont-capital-partners) — VC Fund, 3 deals together
- [ID8 Investments](https://shizune.co/investors/profile/id8-investments) — VC Fund, 3 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 3 deals together
- [METIS innovative](https://shizune.co/investors/profile/metis-innovative) — VC Fund, 3 deals together
- [Neurotechnology Investors](https://shizune.co/investors/profile/neurotechnology-investors-nti) — VC Fund, 3 deals together
- [Uniseed](https://shizune.co/investors/profile/uniseed-vc) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does University of Melbourne invest in?

University of Melbourne invests primarily in Health Care, Biotechnology and Medical startups, most often at Pre-Seed and Grant stage. Most of the 18 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact University of Melbourne?

Public channels for University of Melbourne include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at University of Melbourne?

The team at University of Melbourne includes Cathy Humphreys (Professor), James Demetriou (Business Development Director) and Jane Gunn (Head of Department, Chair of Primary Care Research, Director of the Primary Care Research Unit), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co